Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Hepatic Impairment Compared With Matched Healthy Participants

Novartis Pharmaceuticals · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
safety
hepatic impairment, remibrutinib (lou064), hepatic impairment (hi), pharmacokinetic (pk), safety, tolerability, child-pugh, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 806473
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.